Capital Advisors Ltd’s NantHealth, Inc NH Stock Holding History

Capital Advisors Ltd’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-49	Closed	-$1K	–	1451
2022 Q1	$1K	Buy	+49	New	+$625	﹤0.01%	853

Other funds holding NH

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIC

Hartline Investment Corp Winnetka, Illinois $909M AUM 45.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Capital Advisors Ltd's NH Position: Q2 2022 in Review

Capital Advisors Ltd sold out of NantHealth, Inc (NH) in Q2 2022, closing a stake of 49 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in NH in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 42 funds tracked by Wall St. Rank hold NH as of Q2 2022.

Capital Advisors Ltd reported no remaining NantHealth, Inc position as of Q2 2022 after selling out during the quarter.
Capital Advisors Ltd sold 49 NantHealth, Inc shares in Q2 2022, an estimated $1K.
Capital Advisors Ltd first reported a position in NantHealth, Inc in Q1 2022 and held it in 1 quarter.
Capital Advisors Ltd's NantHealth, Inc position peaked at $1K in Q1 2022.
42 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2022.

Based on Capital Advisors Ltd's 13F filing for Q2 2022, filed 5 Aug 2022.